DepoMed, Inc. (DEPO) Tops Q4 EPS by 93c

March 12, 2014 4:27 PM

DepoMed, Inc. (NASDAQ: DEPO) reported Q4 EPS of $0.72, which may not compare with the analyst estimate of ($0.21). Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found